Growth Metrics

Wave Life Sciences (WVE) Change in Accured Expenses (2016 - 2025)

Wave Life Sciences' Change in Accured Expenses history spans 11 years, with the latest figure at $10.1 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 45.22% year-over-year to $10.1 million; the TTM value through Dec 2025 reached $5.5 million, up 28.92%, while the annual FY2025 figure was $5.5 million, 28.92% up from the prior year.
  • Change in Accured Expenses reached $10.1 million in Q4 2025 per WVE's latest filing, up from $3.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.1 million in Q4 2025 to a low of -$13.3 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $729650.0, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: crashed 102.01% in 2022, then surged 7668.97% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.5 million in 2021, then soared by 85.76% to $6.5 million in 2022, then plummeted by 35.28% to $4.2 million in 2023, then soared by 65.06% to $6.9 million in 2024, then skyrocketed by 45.22% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Change in Accured Expenses are $10.1 million (Q4 2025), $3.5 million (Q3 2025), and $5.2 million (Q2 2025).